Overview

Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
To investigate the comparative tolerability, metabolism and pharmacokinetics of individual enantiomers of PQ in healthy human volunteers. The specific aim is the comparative evaluation of the metabolism, pharmacokinetic behavior, and tolerability of the isomers of PQ (RPQ and SPQ and the racemic mixture RSPQ) in normal healthy human volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
University of Mississippi, Oxford
Treatments:
Primaquine